Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.

Conditions

• Foot Ulcer, Diabetic
• Epidermal Growth Factor

Interventions

• DRUG: recombinant human Epidermal Growth Factor (rhEGF)
• OTHER: Placebo

Sponsor

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)